NCT03830736 is a NA clinical trial of Oat Beverage 1 in Postprandial Glucose Regulation, sponsored by Lund University.

Who is sponsoring NCT03830736?

NCT03830736 is sponsored by Lund University.

What drugs are being tested in NCT03830736?

Interventions in NCT03830736: Oat Beverage 1, Oat Beverage 2, Oat Beverage 3, Oat Beverage 4, Control product.

What condition does NCT03830736 study?

NCT03830736 studies Postprandial Glucose Regulation.

Is NCT03830736 still recruiting?

NCT03830736 is currently completed. Last updated 1 May 2020.

Last reviewed 2020-05-01 · How we verify

NCT03830736

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Health Effects of Oats and Oat Bioactive in Human

Completed NA Last updated 1 May 2020

What this trial tests

NA trial testing Oat Beverage 1 in Postprandial Glucose Regulation in 24 participants. Completed in 30 December 2019.

Timeline

18 February 2019

Primary endpoint
30 May 2019

30 December 2019

Quick facts

Lead sponsor	Lund University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	24
Start date	18 February 2019
Primary completion	30 May 2019
Estimated completion	30 December 2019
Sites	1 location across Sweden

Drugs / interventions tested

Oat Beverage 1
Oat Beverage 2
Oat Beverage 3
Oat Beverage 4
Control product — full drug profile →

Conditions studied

Postprandial Glucose Regulation — all drugs for Postprandial Glucose Regulation →

Sponsor

Lund University

Who can join

Adults 20 to 40, any sex, with Postprandial Glucose Regulation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study is to investigate health effects of oats and oat derived components, in human intervention studies, with the purpose to build new knowledge for development of cardiometabolic protective foods.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oat Polar Lipids Improve Cardiometabolic-Related Markers after Breakfast and a Subsequent Standardized Lunch: A Randomized Crossover Study in Healthy Young Adults.
Hossain MM, Tovar J, Cloetens L, Florido MTS, et al · · 2021 · cited 10× · PMID 33803802 · DOI 10.3390/nu13030988

Verify or expand the search:

Other Lund University trials

Trials by the same sponsor.

NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
NCT07407842 — UPSIDES - Recovery Through Peer Support · NA · enrolling by invitation
NCT07141108 — Self-monitoring and Remote Monitoring of Chronic Pain in Primary Care - Using a Digital Tool to Improve Quality of Life · NA · recruiting
NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03830736 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lund University
Last refreshed: 1 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03830736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing